Life as an HEOR analyst at Vitaccess

Life as an HEOR analyst at Vitaccess

MEET AKOSUA OFORI AND KATIE HALL TELL US ABOUT YOUR ROLE AT VITACCESS Katie: It’s really broad actually, so it’s difficult to describe succinctly! HEOR is an umbrella term. There’s outcomes research, which is my background. This might involve qualitative...
Tech Nation announces upscale 6.0 cohort

Tech Nation announces upscale 6.0 cohort

ONE TO WATCH IN 2021 Tech Nation announces latest upscale programme cohort – 33 Tech Scaleups to watch in 2021 Vitaccess has been selected to join the prestigious Tech Nation Upscale 6.0 program. This is testament to the significant progress the company has made...
Patients with melanoma and adverse events 

Patients with melanoma and adverse events 

Adverse events (AEs), particularly with drug therapies, remain a challenge in modern healthcare. The increasing complexity of cancer therapeutics, an ageing population, and rising multimorbidity all continue to contribute to and complicate safety issues for patients....
Vitaccess awarded Innovate UK loan

Vitaccess awarded Innovate UK loan

Digital healthcare scale-up Vitaccess announces award of prestigious Innovate UK loan. Vitaccess, a full-service digital research provider delivering real-time patient-reported data, has been successful in its application for an Innovate UK loan. The funding is...
Vitaccess donates £10,000 to Melanoma UK

Vitaccess donates £10,000 to Melanoma UK

Award-winning digital health company Vitaccess is delighted to announce that, as part of their syndicated project with patient support charity Melanoma UK, they are donating £10,000 towards an Adamo Horus HS800 mole mapper for the Royal Liverpool and Broadgreen...
Skip to content